JPRN-jRCT1020190017招募中未知
Monitoring Recurrence of Individual tumor by serial Observation of Known gene Alterations - MORIOKA study
ishizuka Satoshi0 个研究点目标入组 200 人开始时间: 2020年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 <= 85age old（—）
- 性别
- All
入选标准
- •>Diagnosis of malignancy. Histologic diagnosis is preferred but not mandatory.
- •>Intention to treat for volume reduction or growth suppression of the tumor. Cases receive secondary treatment are eligible. Cases with nodes or organ metastasis are accepted.
- •>Estimated life expectancy is longer than 180 days.
- •>Stages estimated having approximately 30% recurrence rate.
- •>Pre-treatment blood sample is available.
排除标准
- •>Treatment has initiated without pre-treatment blood sample.
- •>Pregnancy.
- •>Periodical survey is difficult due to location or financial reasons.
- •>Any other ineligible reasons.
研究者
相似试验
尚未招募
不适用
Tracking Residual Disease Using Circulating Tumour DNA In High-Risk Early Breast CancerCancer - BreastBreast CancerACTRN12618001766202Peter MacCallum Cancer Centre100
已完成
不适用
Conservative approach in rectal cancerCancerISRCTN60597075Regional Health and Social Agency (Agenzia Sanitaria e sociale Regionale- Regione Emilia Romagna) (Italy)44
招募中
Unknown
Observational study for residual tumors in low-risk and intermediate-risk neuroblastomasJPRN-UMIN000050009Japan Children's Cancer Group60
尚未招募
Unknown
sing advanced MRI sequence to distinguish between cancer and radiation induced damage in treated brain tumors like GliomaCTRI/2024/03/064109Dr ARPITA SAH
进行中（未招募）
不适用
Pathological response of chemotherapy in oral cancersCTRI/2016/02/006609A60